Jirada Daengprasert

Jirada Daengprasert discloses dealings in JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited to Thai SEC (Form 59). We count 5 filings; the first trade dates from 27 May 2026 and the latest from 10 June 2026.

On the market, this insider has only ever bought: 5 purchases, €14k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

A typical purchase (the median) is worth €1,931. Measured against the company's value, the median purchase equals 0.0089% of market capitalisation, across 3 purchases where it is known. On 3 out of 5 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 40% of cases; the median change was -0.6%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 10 June 2026, the filings show an open-market purchase worth €1,931 in JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited. Publication is fast: at least half of the trades appear on Thai SEC (Form 59) on the same day. That lag is the time during which only the insider knows about the trade. Source: insider filings from Thai SEC (Form 59). Past trades are no guide to future returns.